Kleanthis Xanthopoulos

Kleanthis Xanthopoulos

Director/Board Member presso CONNECT BIOPHARMA HOLDINGS LIMITED

Patrimonio netto: - $ in data 31/03/2024

66 anni
Health Technology
Commercial Services
Finance

Profilo

Kleanthis G.
Xanthopoulos
was the founder of Anadys Pharmaceuticals, Inc. (founded in 1992) and SENTÉ, Inc. (California) (founded in 2007), where he holds the position of Director.
He is also the founder of SENTÉ Labs (founded in 2007) and currently serves as Chairman at Stork Capital SARL (since 2020), Director at Irras AB (since 2015), Director at Suzhou Connect Biopharma Co. Ltd.
(since 2020), Director at Connect Biopharma Holdings Ltd.
(since 2020), President at Helios, Inc., Member-Executive Board at BIOCOM, Managing Partner at Vandel Group LLC, and Managing General Partner at Cerus Advisors DMCC (since 2015).
Dr. Xanthopoulos is also the founder of Shoreline Biosciences, Inc...
Dr. Xanthopoulos's former positions include President, Chief Executive Officer & Director at Regulus Therapeutics, Inc. (2007-2015), Chairman at Apricus Biosciences, Inc. (2011-2019), Chairman at Bioniz Therapeutics, Inc. (2015-2016), Director at ZP Opco, Inc., Director at Biotechnology Innovation Organization, Director at J.E.M.
Capital, Inc. (2013-2014), Managing Director at Enterprise Partners Venture Capital (2007), Director at Odyssey Thera, Inc., Director at Aspirus, Inc., Director at Laboratori Derivati Organici SpA (2016-2017), and Independent Director at Zosano Pharma Corp.
(2013-2021).
Dr. Xanthopoulos also served as Senior Vice President at Ionis Pharmaceuticals, Inc. and Vice President-Genomics & Molecular Biology at Aurora Biosciences Corp.
(1997-2000).
He held the position of Associate Professor at Karolinska Institutet and Section Head at the National Human Genome Research Institute (1995-1997).
Dr. Xanthopoulos obtained a doctorate degree from the University of Stockholm in 1986, a graduate degree from the University of Stockholm in 1982, and an undergraduate degree from Aristotle University of Thessaloniki in 1980.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/03/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Kleanthis Xanthopoulos

SocietàPosizioneInizio
IRRAS AB Director/Board Member 01/06/2015
CONNECT BIOPHARMA HOLDINGS LIMITED Director/Board Member 01/12/2020
Stork Capital SARL Chairman 01/06/2020
Director/Board Member 01/11/2020
Chief Executive Officer -
President -
Vandel Group LLC Corporate Officer/Principal -
Founder 01/01/2007
Corporate Officer/Principal 29/07/2014
░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
Tutte le posizioni attive di Kleanthis Xanthopoulos

Precedenti posizioni note di Kleanthis Xanthopoulos

SocietàPosizioneFine
░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Kleanthis Xanthopoulos

Formazione di Kleanthis Xanthopoulos

University of Stockholm Graduate Degree
Aristotle University of Thessaloniki Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kleanthis Xanthopoulos

Relazioni

100 +

Relazioni di 1° grado

29

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
IONIS PHARMACEUTICALS, INC.

Health Technology

REGULUS THERAPEUTICS INC.

Health Technology

IRRAS AB

Health Technology

Aziende private23

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Finance

Health Technology

Commercial Services

Health Services

Health Technology

Government

Retail Trade

Vandel Group LLC

Finance

Health Technology

Stork Capital SARL

Health Technology

Connect Biopharma Holdings Ltd.

SENTÉ Labs

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Kleanthis Xanthopoulos